Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder

Conditions

• Female Sexual Arousal Disorder
• Female Sexual Dysfunction

Interventions

• DRUG: BZ371A 7.5 mg (1.5 ml)
• DRUG: BZ371A 5.0 mg (1.0 ml)
• DRUG: BZ371A 2.5 mg (0.5 ml)
• DRUG: Placebo (1.5 ml)
• DRUG: Placebo (1.0 ml)
• DRUG: Placebo (0.5 ml)

Sponsor

Biozeus Biopharmaceutical S.A.